Bio-Techne TECH
NASDAQ TECH
$72.43 -0.02 (-0.03%)
As of: Sep 4, 2026 · 2:19 PM EDT

Bio-Techne (TECH) FCF Margin (2009 - 2026)

Bio-Techne (TECH) posted quarterly FCF Margin of 24.91% for Q1 2026, up 1511.0% year-over-year from 1.55% in Q1 2025, and down 3.64% quarter-over-quarter from 25.85% in Q4 2025.

Analysis

Bio-Techne (TECH) FCF Margin (2009 - 2026) Analysis & Trends

Bio-Techne's FCF Margin history runs 18 years deep, the most recent figure standing at 24.91% for Q1 2026.

  • In Q1 2026, FCF Margin rose 1511.0% year-over-year to 24.91%; the TTM figure through Mar 2026 stood at 22.27% (up 400.0% YoY), while the FY2025 annual figure was 21.03%, up 66.0% from the prior year.
  • FCF Margin for Q1 2026 stood at 24.91%, down from 25.85% in the prior quarter.
  • The five-year high for FCF Margin was 2326.25% in Q3 2022, with the low at 7.75% in Q3 2025.
  • The 5-year median for FCF Margin is 21.46% (2022), against an average of 156.49%.
  • The sharpest annual moves came in 2022 and 2023: FCF Margin soared 230981 bps in 2022, then slumped 230972 bps in 2023.
  • Bio-Techne's FCF Margin stood at 21.46% in 2022, then grew by 17 bps to 25.04% in 2023, then advanced by 4 bps to 26.1% in 2024, then decreased by 1 bps to 25.85% in 2025, then dropped by 4 bps to 24.91% in 2026.
  • Business Quant data shows TECH's FCF Margin at 24.91% in Q1 2026, 25.85% in Q4 2025, and 7.75% in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Vertex Pharmaceuticals 138.92 Bn 131.07 Bn 2.84 Bn 30.39%
2 Regeneron Pharmaceuticals 85.55 Bn 77.56 Bn 3.93 Bn 13.35%
3 Argenx Se 63.55 Bn 58.37 Bn 1.37 Bn -
4 Moderna 58.26 Bn 53.13 Bn 52.00 Mn -388.28%
5 Revolution Medicines 44.08 Bn 44.08 Bn - -
6 BeOne Medicines 39.98 Bn 34.89 Bn 1.53 Bn 25.68%
7 Alnylam Pharmaceuticals 35.32 Bn 32.01 Bn 992.69 Mn 22.62%
8 Royalty Pharma 28.42 Bn 27.59 Bn - 70.82%
9 Insmed 27.41 Bn 26.25 Bn 358.27 Mn -22.35%
10 Bio-Techne 11.30 Bn 11.03 Bn 211.39 Mn 27.07%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 27.07%
Mar 31, 2026 24.91%
Dec 31, 2025 25.85%
Sep 30, 2025 7.75%
Jun 30, 2025 29.44%
Mar 31, 2025 9.80%
Dec 31, 2024 26.10%
Sep 30, 2024 18.90%
Jun 30, 2024 18.79%
Mar 31, 2024 21.27%
Dec 31, 2023 25.04%
Sep 30, 2023 16.53%
Jun 30, 2023 24.08%
Mar 31, 2023 13.19%
Dec 31, 2022 21.46%
Sep 30, 2022 17.25%
Jun 30, 2022 30.93%
Mar 31, 2022 19.98%
Dec 31, 2021 33.73%
Sep 30, 2021 16.44%